447 related articles for article (PubMed ID: 32739974)
1. New evidence on prognostic features, prevention and treatment of congenital Cytomegalovirus infection.
Sebghati M; Khalil A
Curr Opin Obstet Gynecol; 2020 Oct; 32(5):342-350. PubMed ID: 32739974
[TBL] [Abstract][Full Text] [Related]
2. No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre.
Chiaie LD; Neuberger P; Vochem M; Lihs A; Karck U; Enders M
Arch Gynecol Obstet; 2018 Jun; 297(6):1389-1395. PubMed ID: 29404743
[TBL] [Abstract][Full Text] [Related]
3. Describing the Impact of Maternal Hyperimmune Globulin and Valacyclovir on the Outcomes of Cytomegalovirus Infection in Pregnancy: A Systematic Review.
Fitzpatrick A; Cooper C; Vasilunas N; Ritchie B
Clin Infect Dis; 2022 Oct; 75(8):1467-1480. PubMed ID: 35438780
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
Blázquez-Gamero D; Galindo Izquierdo A; Del Rosal T; Baquero-Artigao F; Izquierdo Méndez N; Soriano-Ramos M; Rojo Conejo P; González-Tomé MI; García-Burguillo A; Pérez Pérez N; Sánchez V; Ramos-Amador JT; De la Calle M
J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246
[TBL] [Abstract][Full Text] [Related]
5. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.
Hamilton ST; van Zuylen W; Shand A; Scott GM; Naing Z; Hall B; Craig ME; Rawlinson WD
Rev Med Virol; 2014 Nov; 24(6):420-33. PubMed ID: 25316174
[TBL] [Abstract][Full Text] [Related]
6. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
Nigro G
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):977-986. PubMed ID: 29072089
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus in pregnancy: to screen or not to screen.
Walker SP; Palma-Dias R; Wood EM; Shekleton P; Giles ML
BMC Pregnancy Childbirth; 2013 Apr; 13():96. PubMed ID: 23594714
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy.
Nigro G; Muselli M; On Behalf Of The Congenital Cytomegalic Disease Collaborating Group
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376675
[TBL] [Abstract][Full Text] [Related]
9. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
Kagan KO; Enders M; Hoopmann M; Geipel A; Simonini C; Berg C; Gottschalk I; Faschingbauer F; Schneider MO; Ganzenmueller T; Hamprecht K
Ultrasound Obstet Gynecol; 2021 Apr; 57(4):560-567. PubMed ID: 33491819
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and antenatal management of congenital cytomegalovirus infection.
; Hughes BL; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2016 Jun; 214(6):B5-B11. PubMed ID: 26902990
[TBL] [Abstract][Full Text] [Related]
11. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
Shahar-Nissan K; Pardo J; Peled O; Krause I; Bilavsky E; Wiznitzer A; Hadar E; Amir J
Lancet; 2020 Sep; 396(10253):779-785. PubMed ID: 32919517
[TBL] [Abstract][Full Text] [Related]
12. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection during pregnancy: state of the science.
Leruez-Ville M; Foulon I; Pass R; Ville Y
Am J Obstet Gynecol; 2020 Sep; 223(3):330-349. PubMed ID: 32105678
[TBL] [Abstract][Full Text] [Related]
14. Fetal therapies for cytomegalovirus: What we tell prospective parents.
Bartlett AW; Hamilton ST; Shand AW; Rawlinson WD
Prenat Diagn; 2020 Dec; 40(13):1681-1692. PubMed ID: 32271956
[TBL] [Abstract][Full Text] [Related]
15. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
Kagan KO; Enders M; Schampera MS; Baeumel E; Hoopmann M; Geipel A; Berg C; Goelz R; De Catte L; Wallwiener D; Brucker S; Adler SP; Jahn G; Hamprecht K
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
[TBL] [Abstract][Full Text] [Related]
16. Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: A case-series.
De Santis M; Apicella M; De Luca C; D'Oria L; Valentini P; Sanguinetti M; Lanzone A; Scambia G; Santangelo R; Masini L
J Clin Virol; 2020 Jun; 127():104351. PubMed ID: 32325395
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis.
Albright CM; Werner EF; Hughes BL
Am J Perinatol; 2019 Jun; 36(7):678-687. PubMed ID: 30567003
[TBL] [Abstract][Full Text] [Related]
18. Screening, prevention, and treatment of congenital cytomegalovirus.
Johnson J; Anderson B
Obstet Gynecol Clin North Am; 2014 Dec; 41(4):593-9. PubMed ID: 25454992
[TBL] [Abstract][Full Text] [Related]
19. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy.
Yinon Y; Farine D; Yudin MH
Obstet Gynecol Surv; 2010 Nov; 65(11):736-43. PubMed ID: 21375790
[TBL] [Abstract][Full Text] [Related]
20. Antenatal treatment options for primary cytomegalovirus infections.
Kagan KO; Sonek J; Hamprecht K
Curr Opin Obstet Gynecol; 2018 Dec; 30(6):355-360. PubMed ID: 30169462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
